Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 357,710,112
  • Shares Outstanding, K 2,686,520
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.74
  • Price/Sales 4.61
  • Price/Cash Flow 15.85
  • Price/Book 4.76

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.15 +7.12%
on 02/05/18
148.14 -11.67%
on 01/22/18
-16.51 (-11.20%)
since 01/19/18
3-Month
122.15 +7.12%
on 02/05/18
148.32 -11.78%
on 01/17/18
-7.08 (-5.13%)
since 11/20/17
52-Week
118.32 +10.59%
on 02/21/17
148.32 -11.78%
on 01/17/18
+11.99 (+10.09%)
since 02/17/17

Most Recent Stories

More News
What's in the Cards for Geron (GERN) This Earnings Season?

With no approved product in Geron's (GERN) portfolio, investor focus is likely to remain on its sole pipeline candidate, imetelstat, in the Q4 release.

EXAS : 49.08 (+0.45%)
JNJ : 130.77 (-1.79%)
EXEL : 29.19 (+0.03%)
GERN : 2.32 (-2.52%)
Iron Deficiency Anemia - Pipeline Insight, 2018 Featuring Johnson & Johnson, Novartis, Pieris Pharmaceuticals, Rockwell Medical & Shield Therapeutics - ResearchAndMarkets.com

The "Iron Deficiency Anemia - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

JNJ : 130.77 (-1.79%)
NVS : 85.76 (-1.32%)
PIRS : 8.83 (+2.32%)
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including...

JNJ : 130.77 (-1.79%)
Global Over-the-Counter (OTC) Drug Markets 2017-2023: Johnson & Johnson Maintains a Top Market Position Despite Growing Consolidation and Competition - ResearchAndMarkets.com

The "Global Over-the-Counter (OTC) Drug Markets" report has been added to ResearchAndMarkets.com's offering.

JNJ : 130.77 (-1.79%)
World's Largest Recovery App, Sober Grid, Can Now Predict Relapses with Artificial Intelligence

Sober Grid, Inc., a National Science Foundation and National Institute of Health backed company, in partnership with UPenn Perelman School of Medicine, has successfully predicted if someone is going to...

JNJ : 130.77 (-1.79%)
Stocks stretch winning streak to 6 days despite turbulence

NEW YORK (AP) — Stocks closed out their strongest week in five years Friday and have now recovered more than half of the losses they suffered in a plunge at the beginning of the month.

VFC : 73.10 (-2.06%)
CPB : 46.07 (-0.22%)
WFC : 60.30 (+0.58%)
JNJ : 130.77 (-1.79%)
HD : 189.65 (+1.43%)
PFE : 36.01 (-0.69%)
Markets Right Now: Stocks rise for the 6th straight day

NEW YORK (AP) — The latest on developments in financial markets (all times local):

JNJ : 130.77 (-1.79%)
The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson

The Klein Law Firm announces the commencement of an investigation of Johnson & Johnson (NYSE: JNJ) concerning possible violations of federal securities laws.

JNJ : 130.77 (-1.79%)
Watch for Johnson&Johnson to Potentially Pullback After Gaining 1.76% Yesterday

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $130.84 to a high of $133.85. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of...

JNJ : 130.77 (-1.79%)
After Yesterday's Rally of 1.76% Shares Could Potentially Pullback

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $130.84 to a high of $133.85. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of...

JNJ : 130.77 (-1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 136.42
1st Resistance Point 134.79
Last Price 130.85
1st Support Level 131.18
2nd Support Level 129.20

See More

52-Week High 148.32
Fibonacci 61.8% 136.86
Fibonacci 50% 133.32
Last Price 130.85
Fibonacci 38.2% 129.78
52-Week Low 118.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.